BMY Deferred Revenue
Bristol Myers Squibb · Deferred Revenue

BMY Deferred Revenue
Latest reported$0.00period ending
BMY FY Deferred Revenue ($0.00 → $0.00)
Annual deferred revenue
High-resolution chart · PNG
BMY deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 172,000,000 | |
| 83,000,000 | |
| 762,000,000 | |
| 1,003,000,000 | |
| 1,167,000,000 | |
| 756,000,000 | |
| 825,000,000 | |
| 337,000,000 | |
| 402,000,000 | |
| 237,000,000 | |
| 277,000,000 | |
| 447,000,000 | |
| 411,000,000 | |
| 125,000,000 | |
| 32,000,000 | |
| 76,000,000 | |
| 470,000,000 | |
| 2,026,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |